HHS seeks to dismiss Rhode Island lawsuit over reorganization plansnews2025-08-19T19:07:21+00:00August 19th, 2025|Endpoints News|
Researchers cited by HHS on mRNA cuts say their work is misappliednews2025-08-19T17:17:01+00:00August 19th, 2025|Endpoints News|
George Church’s lab gets closer to creating human eggs in a dish, and a new startup plans to finish the jobnews2025-08-19T15:16:55+00:00August 19th, 2025|Endpoints News|
Irish pharma exports to the US decrease after months of stockpilingnews2025-08-19T15:12:03+00:00August 19th, 2025|Endpoints News|
BiomX’s mid-stage cystic fibrosis trial put on clinical hold; Santen makes a deal with RemeGennews2025-08-19T14:53:45+00:00August 19th, 2025|Endpoints News|
Sensorium raises $25M for clinical tests of succulent-derived drug for anxietynews2025-08-19T14:00:51+00:00August 19th, 2025|Endpoints News|
FDA rejects PTC’s Friedreich’s ataxia drugnews2025-08-19T13:45:51+00:00August 19th, 2025|Endpoints News|
Longevity startup Superpower cuts price to $199news2025-08-19T13:02:55+00:00August 19th, 2025|Endpoints News|
Roivant-backed VantAI and Halda line up $1B RIPTAC pactnews2025-08-19T12:00:33+00:00August 19th, 2025|Endpoints News|
Updated: Viking’s stock tanks as mid-stage obesity pill disappoints on efficacy, safetynews2025-08-19T11:30:31+00:00August 19th, 2025|Endpoints News|
